image
Alnylam Pharmaceuticals, Inc. ALNY
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 235.56
-8.67 %
$ 30.4 B
Market Cap
-92.38
P/E
CASH FLOW STATEMENT
104 M OPERATING CASH FLOW
119.24%
Growth Rates
1Year 119.24%
3Years 29.45%
5Years 16.92%
7Years 12.90%
10Years 13.40%
-336 M INVESTING CASH FLOW
-198.61%
Growth Rates
1Year -198.61%
3Years 8.25%
5Years -17.42%
7Years -18.90%
10Years -9.93%
172 M FINANCING CASH FLOW
-59.57%
Growth Rates
1Year -59.57%
3Years -44.28%
5Years 21.33%
7Years -0.46%
10Years -1.53%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Alnylam Pharmaceuticals, Inc.
image
Net Income -440 M
Depreciation & Amortization 97 M
Capital Expenditures -62.2 M
Stock-Based Compensation 222 M
Change in Working Capital 10.8 M
Others 214 M
Free Cash Flow 41.9 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002
OPERATING CASH FLOW
Net Income (440.2) (1 131.2) (852.8) (858.3) (886.1) (761.5) (490.9) (410.1) (290.1) (360.4) (89.2) (106.0) (57.6) (43.5) (47.6) (26.2) (85.5) (34.6) (42.9) (32.7) (25.0) (4.1)
Depreciation & Amortization 97.0 85.5 89.7 74.4 54.4 6.4 13.4 15.1 19.1 11.9 10.2 9.0 5.1 4.9 6.0 5.7 4.1 3.8 3.1 2.4 0.8 36 K
Deferred Income Tax 0 0 (55.7) (54.0) (11.3) (3.6) 1.9 (7.0) 0 (42.3) (2.7) (22.4) 3.5 10.7 (5.2) (5.5) 1.9 (7.9) 0 (4.1) 0 0
Stock Based Compensation 221.7 230.6 165.7 139.9 174.8 157.8 92.8 75.5 45.8 33.1 20.7 12.4 16.8 19.3 20.2 18.0 14.5 8.3 0 4.1 0 0
Other Operating Activities 214.9 309.2 174.2 95.8 (12.6) (6.8) 2.9 1.5 1.0 221.5 0.4 0.4 1.1 3.7 4.9 9.6 7.1 8.4 6.6 7.2 8.5 0.2
Change in Working Capital 10.8 (35.6) (162.8) (12.7) 402.4 45.1 (2.9) 17.2 35.1 (29.4) (8.1) (9.0) (55.9) (79.6) (50.4) 63.9 254.4 (2.7) 16.8 3.5 2.9 2.6
Cash From Operations 104.2 (541.3) (641.7) (615.0) (278.4) (562.6) (382.8) (307.7) (189.1) (165.6) (68.7) (115.6) (87.1) (84.3) (72.1) 65.5 196.5 (24.6) (16.5) (19.6) (12.8) (1.3)
INVESTING CASH FLOW
Capital Expenditures (62.2) (72.1) (76.4) (70.4) (140.2) (126.9) (104.2) (64.6) (12.9) (9.0) (4.0) (8.3) (1.3) (4.7) (4.9) (10.8) (7.8) (5.0) (1.9) (9.0) (3.1) (0.6)
Other Items (274.1) 241.4 (196.9) (365.2) (277.5) 399.8 (186.2) 207.1 (308.4) (539.9) (126.5) 11.7 83.2 22.6 19.4 28.7 (269.6) (25.1) (38.5) (25.6) (0.1) 0
Cash From Investing Activities (336.4) 169.4 (273.3) (435.5) (417.7) 272.9 (290.4) 142.6 (321.3) (548.8) (130.5) 3.4 82.0 17.8 14.4 17.9 (277.4) (30.0) (40.4) (34.6) (3.2) (0.6)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 (3.5) (0.3) (0.6) (0.4) (16.0) (1.4) (0.4) 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 254.0 500.0 200.0 0 0 (120.0) 150.0 0 0 0 0 0 0 0 (6.8) (2.4) 1.7 0.2 5.3 (1.1) 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 172.1 171.7 747.1 695.5 41.3 65.5 83.9 14.1 31.1 29.4 28.7 7.0 0.7 2.7 0 0 0 0 0 0.3 (2.7) 28 K
Cash From Financing Activities 172.1 425.8 1 247.1 995.0 823.2 65.5 1 124.9 177.8 616.2 736.5 200.9 93.4 0.7 3.7 3.5 3.2 58.6 166.6 52.6 51.0 23.7 17.3
CHANGE IN CASH
Net Change In Cash (53.7) 46.4 323.1 (50.6) 127.0 (224.2) 451.7 12.7 105.7 22.0 1.8 (18.8) (4.4) (62.9) (54.3) 86.6 (22.8) 112.2 (4.5) (2.9) 7.7 17.3
FREE CASH FLOW
Free Cash Flow 41.9 (613.3) (718.1) (685.3) (418.6) (689.5) (487.0) (372.3) (202.1) (174.6) (72.7) (124.0) (88.4) (89.1) (77.1) 54.7 188.7 (29.6) (18.4) (28.6) (15.9) (1.8)